PathAI Funding & Investors

Boston, MA

PathAI, Inc. designs and develops AI-powered technology for the pathology laboratory. The Company offers its services in the United States.

Total Amount Raised: $355,200,000

PathAI Funding Rounds

Debt Financing
$100,000,000
Dec 31, 2021
Series C
$165,000,000
May 17, 2021
Series C Investors
D1 Capital Partners
Kaiser Permanente
8VC
Polaris Partners
KdT Ventures
Tiger Global Management
Biospring Partners
Refactor Capital
Adage Capital Management
General Catalyst
General Atlantic
Merck
Bristol-Myers Squibb Company
LabCorp
BIENVILLE
Series B
$15,000,000
Nov 3, 2019
Series B Investors
LabCorp
Bristol-Myers Squibb Company
Merck
Series B
$60,000,000
Apr 16, 2019
Series B Investors
General Atlantic
General Catalyst
Innospark Ventures
Series A
$11,000,000
Nov 2, 2017
Series A Investors
General Catalyst
Pillar VC
Refactor Capital
8VC
DHVC (Danhua Capital)
KdT Ventures
Seed
$4,200,000
Dec 5, 2016
Seed Investors
DHVC (Danhua Capital)
Refactor Capital
8VC
Fairhaven Capital Partners
Pillar VC

Funding info provided by Diffbot.